Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

Insights and Analysis

Life Science Law Update – Key developments for pharma & device companies in EU

The Q1/24 Life Science and Health Care Law Update covers key trends across EU life sciences regulatory, corporate, compliance, competition, and privacy.Key new developments: Pharma: EC ...

News

FTC disputes new slate of Orange Book patents for weight loss, diabetes, asthma, and COPD drugs

On April 30, 2024, the Federal Trade Commission (FTC) announced that it sent a new set of warning letters to ten pharmaceutical companies. The letters inform the companies that the...

News

Home truths: UK CMA wins in dispute over searches of domestic premises

The UK High Court has ruled against the Competition Appeal Tribunal (“CAT”) in a case about the power of the Competition and Markets Authority (“CMA”) to search...

Insights and Analysis

Publication of the General Law on Adequate and Sustainable Food

On April 17, 2024, the General Law of Adequate and Sustainable Food (the “Law”) was published on the Federal Official Gazette, whose principles and bases are aimed at protecting ...

Insights and Analysis

Publication of the General Law on Adequate and Sustainable Food

On April 17, 2024, the General Law of Adequate and Sustainable Food (the “Law”) was published on the Federal Official Gazette, whose principles and bases are aimed at protecting ...

News

UK CMA publishes AI Foundation Models update paper

The UK Competition and Markets Authority (“CMA”) has published an “Update Paper” outlining its evolving views on AI foundation models as well as its approach to...

Insights and Analysis

Reverse DMA: The role of private enforcement

The Digital Markets Act provides not only compliance duties, but also opportunities for those seeking to enforce their rights under the DMA. Be it enhancing interoperability or opening up...

News

FTC continues to highlight FDA Orange Book patent listings

With the recent filing of an amicus brief in a private pharmaceutical patent infringement case, the Federal Trade Commission (FTC) has continued its focus on allegedly “improperly...

News

Commission investigation into termination of pipeline drug: what next for R&D decision-making?

The European Commission has opened a formal investigation into whether Zoetis, a US animal health company, has acted in breach of the abuse of dominance rules by terminating development of...

Loading data